about
Pharmacometabolomics-aided Pharmacogenomics in Autoimmune DiseaseThe Implications of Metabotypes for Rationalizing Therapeutics in Infants and ChildrenePGA: A Web-Based Information System for Translational PharmacogenomicsA European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical PharmacogenomicsDeciphering next-generation pharmacogenomics: an information technology perspective.Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.Whole genome sequencing in pharmacogenomicsDevelopment and validation of a UHPLC-UV method for the determination of a prostate secretory protein 94-derived synthetic peptide (PCK3145) in human plasma and assessment of its stability in human plasma.Nutrigenomics: A controversy.Pharmacometabolomics Informs Viromics toward Precision Medicine.Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients.Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics.Key Pharmacogenomic Considerations for Sickle Cell Disease Patients.Functional Analysis of an (A)γ-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress.Circulating pEGFR is a candidate response biomarker of cetuximab therapy in colorectal cancer.Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological properties.Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancer.In vivo evaluation and in vitro metabolism of leuprolide in mice--mass spectrometry-based biomarker measurement for efficacy and toxicity.Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach.Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.Ovarian malignant ascites-derived lymphocytes stimulated with prothymosin α or its immunoactive decapeptide lyse autologous tumour cells in vitro and retard tumour growth in SCID mice.DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.Advancing Global Precision Medicine: An Overview of Genomic Testing and Counseling Services in Malaysia.Simultaneous absolute quantification of the glucose-dependent insulinotropic polypeptides GIP1-42 and GIP3-42 in mouse plasma by LC/ESI-MS/MS: preclinical evaluation of DP-IV inhibitors.Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients.Pharmacogenomics education and research at the Department of Pharmacy, University of Patras, Greece.Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment.Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping.The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment.Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients.Searching for Clinically Relevant Biomarkers in Geriatric Oncology.Personalized pharmacogenomics profiling using whole-genome sequencingIntegrating Next-Generation Sequencing in the Clinical Pharmacogenomics Workflow
P50
Q26748481-2E006ADF-FF33-443C-B651-19E0A737B593Q26797273-D687BD35-AB0E-4F40-A1BD-971022A5AC19Q28554117-E867D434-5975-4886-AC28-9E787C7FDEA4Q28554199-E89BE406-4594-4868-9478-BDF61026E41EQ33987606-4D52A279-9A36-4C0A-A109-758C61CD7FCCQ34153033-3C06785D-DE60-48EF-A0E3-0F56B0C70179Q35218816-3ACA7157-8C1E-477C-8822-1B6CDD4F793FQ35927899-937D4FDE-F583-45E2-BE9E-3C3BB4E937DEQ36556423-9806A965-0312-4C01-9C00-2CB91B7BC278Q37368628-C5A6104C-D24F-4543-A8BD-FDE7E3EF478CQ38243173-DFB6F19F-DF1B-4E5E-BFBE-BAF8C52D298DQ38680715-B1D64B3F-8579-40C3-9A6E-00B736D59506Q38686013-A91E1860-1865-41EF-9AE8-2B27F6E4CCCFQ38819053-596B83ED-4D32-43B7-819A-5CAF02D4D969Q38947025-A4FFE223-DD94-42B1-B61E-550D8263D660Q39525144-16B05F35-87EE-4F3F-8DAE-D34FC6FCCFEEQ39627769-05945672-6E8E-463C-9254-59C1BFD5EE69Q40098725-2A53C3E0-E058-481C-B6B5-E486CE90B835Q40818625-BB597A2F-43E2-4005-954A-D238505C3E03Q42320992-8F742B82-68D8-4302-9450-49596E297919Q43467080-39732F84-B951-496A-846D-C81B72227114Q43758555-F2909820-A787-4BD3-9BF0-9A5D6633491BQ45939193-FAAB82B9-B630-4002-92D4-B7E1FFAF9801Q46020282-9BA68A16-DC12-464C-A488-A7CE3587C06CQ46261017-2AC518AB-B9A2-486D-A073-551B5DB33FB8Q47121708-7BBEB57E-4AB9-4A8F-9816-D285C5212FB7Q47648687-CB5301EF-92D7-421C-B5BD-EB765046A440Q47719786-A20D31D5-CB7B-4860-8DC9-6BD146E7CB67Q47835926-59034DE9-C61F-4A90-8B4A-4032B592CDE1Q47900162-1FA3E9AE-F19D-4235-8379-4080302EDB4DQ50049202-C34A9928-4F60-41FD-BE00-69512585BFD1Q52590099-E9EC23E4-F8AC-460E-80C2-ABC66D91FC8AQ54123860-0D16D659-CE4C-498E-A56D-03AC5C43F825Q54982160-020AD0A9-AB98-41AD-B922-4BD4E9DC57CEQ57413775-30C0B79C-3610-4E45-8EBD-EC30D2F9D134Q64072007-D10257CC-F6D1-41FE-8A45-B2FDA8FC566F
P50
name
Theodora Katsila
@ast
Theodora Katsila
@en
Theodora Katsila
@nl
type
label
Theodora Katsila
@ast
Theodora Katsila
@en
Theodora Katsila
@nl
prefLabel
Theodora Katsila
@ast
Theodora Katsila
@en
Theodora Katsila
@nl